PT-141 Bremelanotide Description
PT-141 Bremelanotide is a peptide that increases the production of nitric oxide in the body, thus allowing the blood vessels to open up, increasing the blood flow to the penis, making it more significant, and thus enabling a man to have an erection that lasts for a more extended period.
This peptides will not eliminate the low libido, they will reduce it. In addition to being able to lessen the risk of sex, the lower desire can cause a couple of problems such as reduced satisfaction from sex, or even a decreased sex drive altogether, which is not desirable.
Bremelanotide, a brand name for PT-141, has been dubbed “the female Viagra” due to its usage in treating female hypoactive sexual drive disorder in phase llb human clinical trials (HSDD). PT-141 is a melanocortin that primarily binds to the MC-4R and MC-1R receptors. Acute bleeding may be treated with PT-141, according to research conducted in 2009. Melanotan 2 is another synthetic melanocortin from which PT-141 is derived (MT 2)
PT-141 Bremelanotide Research findings
PT-141 is a unique peptide because it activates the MC-4R, affecting sexual desire and behaviour. Agonist binding to MC-4R induces sexual excitement and enhanced copulation in male and female mice. Because PT-141 works differently than medications like Viagra, it can treat sexual arousal issues in men and women that aren’t caused by diminished genital blood flow .
Unresponsive to sildenafil (Viagra), around one-third of males with ED achieved satisfactory erections for sexual intercourse with PT-141 (administered via nasal spray) . In addition, the trial showed a robust dose-dependent response, showing that PT 141 is beneficial in some situations. This indicates that PT-141 may help fix ED when sildenafil has been unsuccessful and may help understand the hypoactive sexual drive .
In HSDD sufferers, it was discontinued from clinical trials. Unbelievably, the drug-enhanced monthly happy sexual experiences and decreased scores of women’s sexual distress without causing significant adverse effects. Many FSD experts were disappointed to learn that the protein was not being further developed despite promising results. The absence of clear endpoints for FSD trials and cultural preconceptions against females’ sexual health is blamed for the delays .
They expect the FDA to create more specific guidelines for examining potentially useful drugs like PT-141. The expert group was also disappointed that the pharmacological treatments were not combined with other proven approaches to treating sexual dysfunction. In addition, they believe peptides like PT-141 Bremelanotide may help overcome initial barriers and initiate psychiatric treatment.
Phase II Reconnect studies using subcutaneous PT141 injections for FSD started in 2017, partly due to discontinued past trials. Rekynda, the newest PT-141 variant, may soon be available in the US. Off-label usage of PT-141 may include male and female sexual problems. These new trials included altered outcomes, which FSD experts think helps approve these drugs.
To treat hemorrhagic shock, PT-141 Bremelanotide was slightly modified in 2009. It decreases ischemia and protects tissues from hypovolemic (hemorrhagic) shock by binding to MC-1R and MC-4R molecules. The medication has no significant adverse effects when given intravenously.
Researchers discovered that the MC-1R possesses potent antifungal and anti-inflammatory effects in a rat model of a specific fungal infection. Notably, current antifungals have limited mechanisms of action and induce substantial, treatment-limiting adverse effects in particular individuals. A treatment option for fungal infections could significantly reduce morbidity and death, especially in immunocompromised individuals .
The MC-1R receptor stimulates DNA repair pathways, making it useful in cancer treatment and prevention . People with MC-1R mutations have an increased risk of basal cell and squamous cell carcinoma. Altered PT-141 may be able to treat or prevent malignancies caused by certain variations .
PT-141 Bremelanotide Peptide summary
Sexual dysfunction is currently the focus of most research on PT-141. However, its use is not limited to sexual dysfunction or bleeding. Thus, MC-4R deficiency or absence is associated with up to 6% of all cases of early-onset obesity, according to some estimates. PT-141 allows us to investigate this particular cause of obesity and show a possible intervention option. MC-1R is involved in pain, inflammation, kidney disease, and infection dissemination.
Buy PT-141 Bremelanotide Peptide vial 10mg
Pharma Lab Global is one of the best locations to purchase high purity PT-141 Bremelanotide for research. Pharma Lab Global is a trusted supplier of peptides and sarms worldwide. You have the option to buy PT-141 Bremelanotide Nasal Spray and buy PT-141 Bremelanotide Pre Mixed peptide from here. Buy PT-141 Bremelanotide from Pharma Lab Global today!
PT-141 Bemelanotide Specifications
Molecular Formula: C50H68N14O10
Molecular Weight: 1025.2 g/mol
Physical Appearance: White Lyophilised Solid
Form: Sterile Filtered White Lyophilize
Storage: Peptides should be refrigerated at 4˚C or below for a period of up to 3 months. To prolong the life span of the peptides they may be placed in a freezer for up to 12 months. Once reconstituted peptides should be refrigerated/stored at 4˚C for up to 30 days.
Disclaimer: All products listed on this website and provided through Pharma Labs Global are intended for medical research purposes only. Pharma Lab Global does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended to be used as a drug, stimulant or for use in any food products.